Skip to content

海港治疗公司

US · SPTX #3277 按市值排名 上市于 2026
17.83 +0.23 +1.31%
实时 - 追踪5344个代码 - 心跳于561秒前 · 2026-10-16 19:30

最新新闻

  • 评级变动
    J.P. Morgan Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $42
    \u5e02\u573a\u8d44\u8baf · 2026/6/9
  • JonesTrading Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $32
    \u5e02\u573a\u8d44\u8baf · 2026/8/26
  • Citi Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $35
    \u5e02\u573a\u8d44\u8baf · 2026/9/10
  • 评级变动
    Analysts Are Bullish on Top NA Stocks: Alamar Biosciences, Inc. (ALMR), Seaport Therapeutics, Inc. (SPTX)
    TipRanks · 2026/6/9
  • 评级变动
    Stifel Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $30
    \u5e02\u573a\u8d44\u8baf · 2026/5/26
  • H.C. Wainwright Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $50
    \u5e02\u573a\u8d44\u8baf · 2026/9/10
  • 评级变动
    J.P. Morgan Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $42
    \u5e02\u573a\u8d44\u8baf · 2026/5/27
  • 评级变动
    Leerink Partners Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $35
    \u5e02\u573a\u8d44\u8baf · 2026/5/26
  • 评级变动
    Leerink Partners Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $35
    \u5e02\u573a\u8d44\u8baf · 2026/5/28
  • 评级变动
    Wolfe Research Initiates Seaport Therapeutics(SPTX.US) With Hold Rating
    \u5e02\u573a\u8d44\u8baf · 2026/7/7
  • 评级变动
    Stifel Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $30
    \u5e02\u573a\u8d44\u8baf · 2026/8/14
  • 评级变动
    Citi Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $35
    \u5e02\u573a\u8d44\u8baf · 2026/5/26
  • JonesTrading Maintains Seaport Therapeutics(SPTX.US) With Buy Rating, Maintains Target Price $32
    \u5e02\u573a\u8d44\u8baf · 2026/9/10
  • 评级变动
    H.C. Wainwright Initiates Seaport Therapeutics(SPTX.US) With Buy Rating, Announces Target Price $50
    \u5e02\u573a\u8d44\u8baf · 2026/7/16
  • 评级变动
    Citi Sticks to Its Buy Rating for Seaport Therapeutics, Inc. (SPTX)
    TipRanks · 2026/6/2
  • 评级变动
    Analysts Conflicted on These NA Names: SailPoint, Inc. (SAIL) and Seaport Therapeutics, Inc. (SPTX)
    TipRanks · 2026/9/10
  • Analysts Offer Insights on NA Companies: Seaport Therapeutics, Inc. (SPTX), Navan, Inc. Class A (NAVN) and International Business Machines (IBM)
    TipRanks · 2026/9/10
  • 评级变动
    Seaport Therapeutics, Inc. (SPTX) Gets a Buy From Stifel Nicolaus
    TipRanks · 2026/8/13

新闻标题为自动聚合内容,未经我们团队独立核实或编辑。

报价时间 2026-10-16 19:30:04 · 仅供参考,不构成投资建议,也未考虑您的具体情况。

海港治疗公司 讨论区 0 条评论

发表评论